|Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation|
Antimicrobial Agents and Chemotherapy
American Society for Microbiology.
|Mukaide, M; Tanaka, Y; ShinI, T; Yuen, MF; Kurbanov, F; Yokosuka, O; Sata, M; Karino, Y; Yamada, G; Sakaguchi, K; Orito, E; Inoue, M; Baqai, S; Lai, CL; Mizokami, M||2010||245|
|Three-year assessment of entecavir resistance in chronic hepatitis B patients and the mechanism of viral breakthrough by the resistance substitutions|
John Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
|Tanaka, Y; Mukaide, M; Yuen, RMF; Shin, IT; Orito, E; Kurbanov, F; Fukai, K; Yokosuka, O; Sata, M; Ide, T; Karino, Y; Yamada, G; Sakaguchi, K; Inoue, M; Gish, RG; Lai, CL; Mizokami, M||2008||224|
|Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma|
Journal of Hepatology
Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
|Tanaka, Y; Mukaide, M; Orito, E; Yuen, MF; Ito, K; Kurbanov, F; Sugauchi, F; Asahina, Y; Izumi, N; Kato, M; Lai, CL; Ueda, R; Mizokami, M||2006||197|
|Two subtypes (subgenotypes) of hepatitis B virus genotype C: A novel subtyping assay based on restriction fragment length polymorphism|
Blackwell Publishing Ltd.
|Tanaka, Y; Orito, E; Yuen, MF; Mukaide, M; Sugauchi, F; Ito, K; Ozasa, A; Sakamoto, T; Kurbanov, F; Lai, CL; Mizokami, M||2005||221|